These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30290590)

  • 1. Malakoplakia as a cause of severe hypercalcemia through ectopic 25-hydroxyvitamin D3 1-alpha-hydroxylase expression: A case report.
    Chemouny JM; Sannier A; Hanouna G; Champion L; Vrtovsnik F; Daugas E
    Medicine (Baltimore); 2018 Oct; 97(40):e12090. PubMed ID: 30290590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
    Ketha H; Wadams H; Lteif A; Singh RJ
    J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
    Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
    J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
    Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
    J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia worsened after vitamin D supplementation in a sarcoidosis patient: A case report.
    Mio K; Haruhara K; Shimizu A; Oshiro K; Kawai R; Ikeda M; Yokoo T
    Medicine (Baltimore); 2022 Oct; 101(40):e30883. PubMed ID: 36221396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
    Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
    Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal 24-hour urine calcium concentrations after long-term daily oral intake of vitamin D in doses ranging from 5000 to 50,000 international units in 14 adult hospitalized psychiatric patients.
    Repas SJ; Schmeusser BN; McCullough WP; Lehrer DS; Travers JB; McCullough PJ
    J Steroid Biochem Mol Biol; 2023 Jul; 231():106329. PubMed ID: 37182752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
    Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
    Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and its refractoriness of 25-hydroxyvitamin D3 metabolism in vitamin D deficiency.
    Takahashi N; Miyaura C; Horiuchi N; Suda T
    J Nutr Sci Vitaminol (Tokyo); 1981; 27(5):429-37. PubMed ID: 7320768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
    Kallas M; Green F; Hewison M; White C; Kline G
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3111-7. PubMed ID: 20427501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial.
    Marwaha RK; Garg MK; Sethuraman G; Gupta N; Mithal A; Dang N; Kalaivani M; Ashraf Ganie M; Narang A; Arora P; Singh A; Chadha A; Manchanda RK
    Br J Nutr; 2019 Mar; 121(5):538-548. PubMed ID: 30843501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A rare cause of kidney injury: vitamin D3 intoxication].
    Hutkai D; Bodor M
    Orv Hetil; 2023 Nov; 164(47):1871-1876. PubMed ID: 38007710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia, nephrolithiasis, and hypervitaminosis D precipitated by supplementation in a susceptible individual.
    Haridas K; Holick MF; Burmeister LA
    Nutrition; 2020 Jun; 74():110754. PubMed ID: 32222584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
    Tenenhouse HS; Jones G
    Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of calf renal 25-hydroxyvitamin D-hydroxylase activities by calcium-regulating hormones.
    Engstrom GW; Goff JP; Horst RL; Reinhardt TA
    J Dairy Sci; 1987 Nov; 70(11):2266-71. PubMed ID: 3693631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A young girl with recurrent calculosis and hypercalcemia].
    Di Maio F; Vittori M; Bassi P; Fulignati P; D'Alonzo S; Ferraro PM
    G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal renal mitochondrial 25-hydroxyvitamin D3-1-hydroxylase activity in the vitamin D and calcium deficient X-linked Hyp mouse.
    Tenenhouse HS
    Endocrinology; 1983 Aug; 113(2):816-8. PubMed ID: 6683624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.